Filter
News & Insights
- Clinical & Medical AffairsClinical Insider
PE-backed ACRS buys Elixia to extend site network
Read More - Clinical & Medical AffairsClinical Insider
At a “tipping point” in history: Microsoft predicts AI revolution in healthcare
Read More - Clinical & Medical AffairsClinical Insider
Intensity Therapeutics calls on SAKK for cancer drug trial
Read More - Clinical & Medical AffairsClinical Insider
Blackstone wants to take Japanese SMO I’rom private
Read More - Clinical & Medical AffairsClinical Insider
MSF says TB trial cost $36 million and calls for transparency on drug study costs
Read More - Clinical & Medical AffairsClinical Insider
GSK looks at using polygenic risk scores in trial design through new pact
Read More - Clinical & Medical AffairsClinical Insider
Ephicacy buys ARA to add biostats and data management capabilities
Read More - Clinical & Medical AffairsClinical Insider
Alcanza buys FDI in tenth takeover since 2021
Read More - Clinical & Medical AffairsClinical Insider
Quanticate teams with machine learning firm PhaseV with an eye on adaptive trials
Read More - Clinical & Medical AffairsClinical Insider
Patient group says online tool will help connect myeloma sufferers with studies
Read More - Clinical & Medical AffairsClinical Insider
Ulysses secures funding for hiring and expansion odyssey
Read More - Clinical & Medical AffairsClinical Insider
A2 Healthcare sets up in Boston to help biopharma with Japanese trials
Read More - Clinical & Medical AffairsClinical Insider
Influenza highest pandemic risk according to EU clinical research network
Read More - Clinical & Medical AffairsClinical Insider
CDER launches C3TI to drive innovation in clinical trials
Read More - Clinical & Medical AffairsClinical Insider
NCTN to use Natera biomarker to guide treatment in urothelial cancer trial
Read More - Clinical & Medical AffairsClinical Insider
Explainer animations increasingly common in UK clinical trials, says study
Read More - Clinical & Medical AffairsClinical Insider
Experts predict tech innovation will establish three-phase trial model for new drugs
Read More - Clinical & Medical AffairsClinical Insider
EMA shares details of stakeholder collaboration platform
Read More - Clinical & Medical AffairsClinical Insider
Resonance Health to buy TrialsWest to build presence in study space
Read More - Clinical & Medical AffairsClinical Insider
Study says regulations covering multi-drug “platform studies” should be more flexible
Read More